Healthcare Industry Reports

Reports > Healthcare > Selected Report

North America Deferasirox Market Report for Period 2011 to 2022 Market Share, Size, Analysis, Historical Data, Forecast and Company Profiles

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.


Scope of the Report
This report focuses on the Deferasirox in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Novartis
Cipla
Sun Pharma
Natco Pharma

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
500 mg/Tablet
250 mg/Tablet
125 mg/Tablet
Others

Market Segment by Applications, can be divided into
Transfusional Iron Overload
NTDT Caused Iron Overload

There are 15 Chapters to deeply display the North America Deferasirox market.

Chapter 1, to describe Deferasirox Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force

Chapter 2, to analyze the manufacturers of Deferasirox, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Deferasirox, for each country, from 2012 to 2017

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications

Chapter 10, Deferasirox market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers)

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Deferasirox Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Deferasirox Introduction
1.2 Market Analysis by Type
1.2.1 500 mg/Tablet
1.2.2 250 mg/Tablet
1.2.3 125 mg/Tablet
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Transfusional Iron Overload
1.3.2 NTDT Caused Iron Overload
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Profile
2.1.2 Deferasirox Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Novartis Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Novartis News
2.2 Cipla
2.2.1 Profile
2.2.2 Deferasirox Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Cipla Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Cipla News
2.3 Sun Pharma
2.3.1 Profile
2.3.2 Deferasirox Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Sun Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Sun Pharma News
2.4 Natco Pharma
2.4.1 Profile
2.4.2 Deferasirox Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Natco Pharma Deferasirox Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Natco Pharma News
3 North America Deferasirox Market Competition, by Manufacturer
3.1 North America Deferasirox Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Deferasirox Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Deferasirox Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Deferasirox Manufacturer Market Share
3.4.2 Top 5 Deferasirox Manufacturer Market Share
3.5 Market Competition Trend
4 North America Deferasirox Market Analysis by Countries
4.1 North America Deferasirox Sales Market Share by Countries
4.2 North America Deferasirox Sales by Countries (2012-2017)
4.3 North America Deferasirox Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Deferasirox by Type
5.1 North America Deferasirox Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Deferasirox Sales and Market Share by Type (2012-2017)
5.1.2 North America Deferasirox Revenue and Market Share by Type (2012-2017)
5.2 500 mg/Tablet Sales Growth and Price
5.2.1 North America 500 mg/Tablet Sales Growth (2012-2017)
5.2.2 North America 500 mg/Tablet Price (2012-2017)
5.3 250 mg/Tablet Sales Growth and Price
5.3.1 North America 250 mg/Tablet Sales Growth (2012-2017)
5.3.2 North America 250 mg/Tablet Price (2012-2017)
5.4 125 mg/Tablet Sales Growth and Price
5.4.1 North America 125 mg/Tablet Sales Growth (2012-2017)
5.4.2 North America 125 mg/Tablet Price (2012-2017)
5.5 Others Sales Growth and Price
5.5.1 North America Others Sales Growth (2012-2017)
5.5.2 North America Others Price (2012-2017)
6 North America Market Segmentation Deferasirox by Application
6.1 North America Deferasirox Sales Market Share by Application (2012-2017)
6.2 Transfusional Iron Overload Sales Growth (2012-2017)
6.3 NTDT Caused Iron Overload Sales Growth (2012-2017)
7 United States Deferasirox Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Deferasirox Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Deferasirox Sales and Market Share by Type
7.3 United States Deferasirox Sales by Application (2012-2017)
7.4 United States Deferasirox Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Deferasirox Sales and Market Share by Manufacturer
7.4.2 United States Deferasirox Revenue and Market Share by Manufacturer
7.5 United States Deferasirox Export and Import (2012-2017)
8 Canada Deferasirox Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Deferasirox Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Deferasirox Sales and Market Share by Type
8.3 Canada Deferasirox Sales by Application (2012-2017)
8.4 Canada Deferasirox Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Deferasirox Sales and Market Share by Manufacturer
8.4.2 Canada Deferasirox Revenue and Market Share by Manufacturer
8.5 Canada Deferasirox Export and Import (2012-2017)
9 Mexico Deferasirox Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Deferasirox Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Deferasirox Sales and Market Share by Type
9.3 Mexico Deferasirox Sales by Application (2012-2017)
9.4 Mexico Deferasirox Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Deferasirox Sales and Market Share by Manufacturer
9.4.2 Mexico Deferasirox Revenue and Market Share by Manufacturer
9.5 Mexico Deferasirox Export and Import (2012-2017)
10 Deferasirox Market Forecast (2017-2022)
10.1 North America Deferasirox Sales, Revenue and Growth Rate (2017-2022)
10.2 Deferasirox Market Forecast by Countries (2017-2022)
10.2.1 United States Deferasirox Forecast (2017-2022)
10.2.2 Canada Deferasirox Forecast (2017-2022)
10.2.3 Mexico Deferasirox Forecast (2017-2022)
10.3 Deferasirox Market Forecast by Type (2017-2022)
10.4 Deferasirox Market Forecast by Application (2017-2022)
11 Deferasirox Manufacturing Cost Analysis
11.1 Deferasirox Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Deferasirox
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Deferasirox Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Deferasirox Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 28386

Category: 11

Published date: 2017-09-15 14:29:49

Number of Pages: 119

Publisher Name: GIR

Over all Rating: 82 % (Average of Ratings provided by clients)